Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R | Q15722 | 19/20 | 0.41 |
| ▸ | LTB4R2 | Q9NPC1 | 18/20 | 0.41 |
| ▸ | RARA | P10276 | 1/20 | 0.37 |
| ▸ | RARB | P10826 | 1/20 | 0.37 |
| ▸ | RARG | P13631 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19697386 | 0.89 | RARA (0.44) | LTB4RLTB4R2RARARARBRARG | |
| SCHEMBL19796823 | 0.88 | RARB (0.37) | LTB4RLTB4R2RARB | |
| SCHEMBL19804779 | 0.86 | SLC6A9 (0.38) | LTB4RLTB4R2RARARARBRARG | |
| SCHEMBL19804533 | 0.85 | RARB (0.44) | LTB4RLTB4R2RARARARBRARG | |
| SCHEMBL19803286 | 0.84 | POLB (0.40) | RARARARBRARG | |
| SCHEMBL19804454 | 0.84 | RARA (0.39) | LTB4RLTB4R2RARARARBRARG | |
| SCHEMBL19804516 | 0.83 | RARB (0.43) | LTB4RLTB4R2RARARARBRARG | |
| SCHEMBL19804377 | 0.83 | EGFR (0.39) | LTB4RLTB4R2RARARARBRARG | |
| SCHEMBL19801710 | 0.82 | POLB (0.42) | — | |
| SCHEMBL19804042 | 0.82 | RARA (0.36) | RARARARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180023001-A1 | COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, C1S, AP3D1 | LTB4R 2415/4885LTB4R2 2159/4885RARA 3585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.